HOME» スタッフ紹介»業績紹介-眞杉洋平

■眞杉　洋平

論文

2024
  1. Asakura T., Okuda K., Chen G., Dang H., Kato T., Mikami Y., Schworer S. A., Gilmore R. C., Radicioni G., Hawkins P., Barbosa Cardenas S. M., Saito M., Cawley A. M., De La Cruz G., Chua M., Alexis N. E., Masugi Y., Noone P. G., Ribeiro C. M. P., Kesimer M., Olivier K. N., Hasegawa N., Randell S. H., O'neal W. K., Boucher R. C. Proximal and Distal Bronchioles Contribute to the Pathogenesis of Non-Cystic Fibrosis Bronchiectasis.Am J Respir Crit Care Med. 2024;209(4):374-89.
  2. Hayashi M., Obara H., Matsuda S., Homma K., Sasaki J., Matsubara K., Higuchi M., Sano M., Masugi Y., Kitagawa Y. Protective Effects of Hydrogen Gas Inhalation for Hindlimb Ischaemia-Reperfusion Injury in a Mouse Model.Eur J Vasc Endovasc Surg. 2024;68(1):120-8.
  3. Ishida M., Fujii T., Kishiwada M., Shibuya K., Satoi S., Ueno M., Nakata K., Takano S., Uchida K., Ohike N., Masugi Y., Furukawa T., Hirabayashi K., Fukushima N., Yi S. Q., Isayama H., Itoi T., Ohtsuka T., Okusaka T., Inoue D., Kitagawa H., Takaori K., Tani M., Nagakawa Y., Yoshitomi H., Unno M., Takeyama Y. Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition.J Hepatobiliary Pancreat Sci. 2024.
  4. Maeda K., Suzuki T., Masugi Y., Tsuji O., Iwamoto T., Nakamura M. Modified Intravascular Stent for Microvascular Suture in a Rat Superficial Femoral Artery.Ann Plast Surg. 2024.
  5. Nakano Y., Shimane G., Nakamura K., Takamatsu R., Aimono E., Yagi H., Abe Y., Hasegawa Y., Hori S., Tanaka M., Masugi Y., Kitago M., Nishihara H., Kitagawa Y. Next-generation sequencing to identify genetic mutations in pancreatic cancer using intraoperative peritoneal washing fluid. Oncol Lett. 2024;27(4):139.
  6. Ono T., Suzuki T., Nagoshi N., Masugi Y., Maeda K., Hashimoto S., Watanabe S., Iwamoto T., Taguchi T., Nakamura M. Alaska Pollock-derived Gelatin Sealant has Higher Sealing Strength than, and Comparable Biocompatibility with, Fibrin Sealant in Porcine and Rat Dural Injury Models. Spine (Phila Pa 1976). 2024;49(13):E200-E7.
  7. Ozawa H., Haratake N., Nakashoji A., Daimon T., Bhattacharya A., Wang K., Shigeta K., Fushimi A., Fukuda K., Masugi Y., Yamaguchi R., Kitago M., Kawakubo H., Kitagawa Y., Kufe D. MUC1-C Dependence for the Progression of Pancreatic Neuroendocrine Tumors Identifies a Druggable Target for the Treatment of This Rare Cancer.Biomedicines. 2024;12(7).
  8. Sato Y., Hishiki T., Masugi Y., Florence L., Yu Y. M. Vitamin D administration increases serum alanine concentrations in thermally injured mice.Biochem Biophys Res Commun. 2024;736:150505.
  9. Shimane G., Nakano Y., Matsuda S., Kitago M., Masugi Y., Nakamura K., Nakamura Y., Yagi H., Abe Y., Hasegawa Y., Hori S., Tanaka M., Takemura R., Nishihara H., Kitagawa Y. Molecular diagnosis for detecting KRAS mutation in peritoneal washing fluid of pancreatic ductal adenocarcinoma. Sci Rep. 2024;14(1):21732.
  10. Tanaka H., Asakura T., Okamori S., Furuuchi K., Yagi M., Nakayama Y., Kuramoto J., Yagi K., Hase I., Kamata H., Fujiwara K., Nakao A., Masugi Y., Sato Y., Kanai Y., Namkoong H., Fukunaga K., Nakagawa T., Morimoto K., Fujita M., Hasegawa N. Distinctive clinical features of radiological pleuroparenchymal fibroelastosis with nontuberculous mycobacterial pulmonary disease: A multicenter retrospective cohort study.Int J Infect Dis. 2024;148:107233.
2023
  1. Masugi Y., Takamatsu M., Tanaka M., Hara K., Inoue Y., Hamada T., Suzuki T., Arita J., Hirose Y., Kawaguchi Y., Nakai Y., Oba A., Sasahira N., Shimane G., Takeda T., Tateishi K., Uemura S., Fujishiro M., Hasegawa K., Kitago M., Takahashi Y., Ushiku T., Takeuchi K., Sakamoto M., Japan G. T. K. Pancreatic Cancer Study Group in. Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression.J Pathol Clin Res. 2023;9(5):339-53.
  2. Kubo A., Masugi Y. (co-first author), Hase T., Nagashima K., Kawai Y., Takizawa M., Hishiki T., Shiota M., Wakui M., Kitagawa Y., Kabe Y., Sakamoto M., Yachie A., Hayashida T., Suematsu M. Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS Imaging.Antioxidants (Basel). 2023;12(2).
  3. Hayashi K., Kitago M., Abe Y., Yagi H., Hasegawa Y., Hori S., Tanaka M., Nakano Y., Asakura K., Masugi Y., Kitagawa Y. Long-term survival after surgical resection for bone metastasis from pancreatic cancer: A case report.Medicine (Baltimore). 2023;102(46):e35856.
  4. Matsuda K., Kurebayashi Y., Masugi Y., Yamazaki K., Ueno A., Tsujikawa H., Ojima H., Kitago M., Itano O., Shinoda M., Abe Y., Sakamoto M. Immunovascular microenvironment in relation to prognostic heterogeneity of WNT/beta-catenin-activated hepatocellular carcinoma.Hepatol Res. 2023;53(4):344-56.
  5. Nakajima Y., Iwasaki E., Kayashima A., Machida Y., Kawasaki S., Horibe M., Kawaida M., Masugi Y., Iwata T., Kanai T. Successful radiotherapy for recurrent obstructive pancreatitis secondary to pancreatic metastasis from cervical squamous-cell carcinoma.Clin J Gastroenterol. 2023;16(5):755-60.
  6. Ugai T., Shimizu T., Kawamura H., Ugai S., Takashima Y., Usui G., Vayrynen J. P., Okadome K., Haruki K., Akimoto N., Masugi Y., Da Silva A., Mima K., Zhang X., Chan A. T., Wang M., Garrett W. S., Freeman G. J., Meyerhardt J. A., Nowak J. A., Song M., Giannakis M., Ogino S. Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD-L1) expression in colorectal carcinoma.Clin Transl Immunology. 2023;12(8):e1453
2022
  1. Masugi Y., Abe T., Yamazaki K., Ueno A., Sakamoto M. Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen-Response.Clin Cancer Res. 2022;28(2):427.
  2. Suzuki T., Masugi Y. (co-first author), Inoue Y., Hamada T., Tanaka M., Takamatsu M., Arita J., Kato T., Kawaguchi Y., Kunita A., Nakai Y., Nakano Y., Ono Y., Sasahira N., Takeda T., Tateishi K., Uemura S., Koike K., Ushiku T., Takeuchi K., Sakamoto M., Hasegawa K., Kitago M., Takahashi Y., Fujishiro M., Japan G. T. K. Pancreatic Cancer Study Group in. KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.Cancer Sci. 2022;113(9):3097-109.
  3. Abe K., Kitago M., Matsuda S., Shinoda M., Yagi H., Abe Y., Oshima G., Hori S., Endo Y., Yokose T., Miura E., Kubota N., Ueno A., Masugi Y., Ojima H., Sakamoto M., Kitagawa Y. Epstein-Barr virus-associated inflammatory pseudotumor variant of follicular dendritic cell sarcoma of the liver: a case report and review of the literature.Surg Case Rep. 2022;8(1):220.
  4. Kurebayashi Y., Matsuda K., Ueno A., Tsujikawa H., Yamazaki K., Masugi Y., Kwa W. T., Effendi K., Hasegawa Y., Yagi H., Abe Y., Kitago M., Ojima H., Sakamoto M. Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironments. Hepatology. 2022;75(5):1139-53.
  5. Mizota T., Hishiki T., Shinoda M., Naito Y., Hirukawa K., Masugi Y., Itano O., Obara H., Kitago M., Yagi H., Abe Y., Matsubara K., Suematsu M., Kitagawa Y. The hypotaurine-taurine pathway as an antioxidative mechanism in patients with acute liver failure.J Clin Biochem Nutr. 2022;70(1):54-63.
  6. Oshima Y., Sano M., Kajiwara I., Ichimaru Y., Itaya T., Kuramochi T., Hayashi E., Kim J., Kitajima O., Masugi Y., Masamune A., Ijichi H., Ishii Y., Suzuki T. Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma.Br J Anaesth. 2022;128(4):679-90.
  7. Tsuchiya T., Saisho Y., Inaishi J., Sasaki H., Sato M., Nishikawa M., Masugi Y., Yamada T., Itoh H. Increased alpha cell to beta cell ratio in patients with pancreatic cancer.Endocr J. 2022;69(12):1407-14.
  8. 岡田 はるか, 岩崎 栄典, 中島 悠貴, 茅島 敦人, 町田 雄二郎, 原 健佑, 眞杉 洋平. 内視鏡的乳頭切除術を施行した十二指腸乳頭部Gangliocytic paragangliomaの1例.胆道. 2022;36(5):610-7.
2021
  1. Ogawa Y., Masugi Y. (co-first author), Abe T., Yamazaki K., Ueno A., Fujii-Nishimura Y., Hori S., Yagi H., Abe Y., Kitago M., Sakamoto M. Three Distinct Stroma Types in Human Pancreatic Cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen.Clin Cancer Res. 2021;27(1):107-19.
  2. Abe K., Kitago M., Masugi Y., Iwasaki E., Yagi H., Abe Y., Hasegawa Y., Fukuhara S., Hori S., Tanaka M., Nakano Y., Yokose T., Shimane G., Sakamoto M., Kitagawa Y. Indication for resection and possibility of observation for intraductal papillary mucinous neoplasm with high-risk stigmata.Pancreatology. 2021;21(4):755-62.
  3. Honda K., Hishiki T., Yamamoto S., Yamamoto T., Miura N., Kubo A., Itoh M., Chen W. Y., Takano M., Yoshikawa T., Kasamatsu T., Sonoda S., Yoshizawa H., Nakamura S., Itai Y., Shiota M., Koike D., Naya M., Hayakawa N., Naito Y., Matsuura T., Iwaisako K., Masui T., Uemoto S., Nagashima K., Hashimoto Y., Sakuma T., Matsubara O., Huang W., Ida T., Akaike T., Masugi Y., Sakamoto M., Kato T., Ino Y., Yoshida H., Tsuda H., Hiraoka N., Kabe Y., Suematsu M. On-tissue polysulfide visualization by surface-enhanced Raman spectroscopy benefits patients with ovarian cancer to predict post-operative chemosensitivity.Redox Biol. 2021;41:101926.
  4. Kojima H., Kitago M., Iwasaki E., Masugi Y., Matsusaka Y., Yagi H., Abe Y., Hasegawa Y., Hori S., Tanaka M., Nakano Y., Takemura Y., Fukuhara S., Ohara Y., Sakamoto M., Okuda S., Kitagawa Y. Peritoneal dissemination of pancreatic cancer caused by endoscopic ultrasound-guided fine needle aspiration: A case report and literature review.World J Gastroenterol. 2021;27(3):294-304.
  5. Komine R., Kojima M., Ishi G., Kudo M., Sugimoto M., Kobayashi S., Takahashi S., Konishi M., Kobayashi T., Akimoto T., Murakami A., Sasaki M., Tanaka M., Matsuzaki A., Ohike N., Uchida K., Sugiyama T., Hirabayashi K., Tajiri T., Ishida K., Kai K., Omori Y., Notohara K., Yamaguchi H., Matsuda Y., Naito Y., Fukumura Y., Hamada Y., Mihara Y., Masugi Y., Gotohda N., Harada K., Fukushima N., Furukawa T. Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin.Cancer Med. 2021;10(11):3499-510.
  6. Sano M., Takahashi R., Ijichi H., Ishigaki K., Yamada T., Miyabayashi K., Kimura G., Mizuno S., Kato H., Fujiwara H., Nakatsuka T., Tanaka Y., Kim J., Masugi Y., Morishita Y., Tanaka M., Ushiku T., Nakai Y., Tateishi K., Ishii Y., Isayama H., Moses H. L., Koike K. Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.Gut. 2021;70(9):1713-23.
  7. Shigenobu T., Takahashi Y., Masugi Y., Hanawa R., Matsushita H., Tajima A., Kuroda H. Micropapillary Predominance Is a Risk Factor for Brain Metastasis in Resected Lung Adenocarcinoma.Clin Lung Cancer. 2021;22(6):e820-e8.
  8. Ugai T., Zhao M., Shimizu T., Akimoto N., Shi S., Takashima Y., Zhong R., Lau M. C., Haruki K., Arima K., Fujiyoshi K., Langworthy B., Masugi Y., Da Silva A., Nosho K., Baba Y., Song M., Chan A. T., Wang M., Meyerhardt J. A., Giannakis M., Vayrynen J. P., Nowak J. A., Ogino S. Association of PIK3CA mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma.Oncoimmunology. 2021;10(1):1956173.
  9. 阿部 紘大, 北郷 実, 眞杉 洋平, 篠田 昌宏, 八木 洋, 阿部 雄太, 大島 剛, 堀 周太郎, 益田 悠貴, 林 航輝, 北川 雄光. 膵体尾部脂肪置換により残膵非再建とした膵頭十二指腸切除を施行した2例. 日本消化器外科学会雑誌. 2021;54(7):480-9.
2020
  1. Fujita Y., Matsuda S., Sasaki Y., Masugi Y. (corresponding author), Kitago M., Yagi H., Abe Y., Shinoda M., Tokino T., Sakamoto M., Kitagawa Y. Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis. Cancer Sci. 2020;111(2):739-48.
  2. Adachi M, Masugi Y, Yamazaki K, Emoto K, Kobayashi Y, Tominaga E, Banno K, Aoki D, Sakamoto M. Upregulation of cyclase-associated actin cytoskeleton regulatory protein 2 in epithelial ovarian cancer correlates with aggressive histologic types and worse outcomes.Jpn J Clin Oncol 2020;50(6):643-52.
  3. Du C., Da Silva A., Morales-Oyarvide V., Dias Costa A., Kozak M. M., Dunne R. F., Rubinson D. A., Perez K., Masugi Y., Hamada T., Brais L. K., Yuan C., Babic A., Ducar M. D., Thorner A. R., Aguirre A., Kulke M. H., Ng K., Clancy T. E., Findeis-Hosey J. J., Chang D. T., Hornick J. L., Fuchs C. S., Ogino S., Koong A. C., Hezel A. F., Wolpin B. M., Nowak J. A. Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma.Cancer Epidemiol Biomarkers Prev. 2020;29(8):1586-95.
  4. Haruki K., Kosumi K., Hamada T., Twombly T. S., Vayrynen J. P., Kim S. A., Masugi Y., Qian Z. R., Mima K., Baba Y., Da Silva A., Borowsky J., Arima K., Fujiyoshi K., Lau M. C., Li P., Guo C., Chen Y., Song M., Nowak J. A., Nishihara R., Yanaga K., Zhang X., Wu K., Bullman S., Garrett W. S., Huttenhower C., Meyerhardt J. A., Giannakis M., Chan A. T., Fuchs C. S., Ogino S. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.J Pathol. 2020;250(4):397-408.
  5. Hayashi Y., Hosoe N., Takabayashi K., Kamiya K. J. L., Mutaguchi M., Miyanaga R., Hirata K., Fukuhara S., Mikami Y., Sujino T., Masugi Y., Naganuma M., Ogata H., Kanai T. Clinical and Endoscopic Characteristics of Pyogenic Granuloma in the Small Intestine: A Case Series with Literature Review.Intern Med. 2020;59(4):501-5.
  6. Kisu I., Banno K., Obara H., Kato Y., Yamada Y., Matsubara K., Matoba Y., Adachi M., Emoto K., Masugi Y., Saiki Y., Ishigaki H., Itagaki I., Kawamoto I., Iwatani C., Nakagawa T., Murase M., Tsuchiya H., Nakagawa K., Shiina T., Aoki D. Experimental techniques for the development of a uterus transplantation model in cynomolgus macaques.J Obstet Gynaecol Res. 2020;46(11):2251-60.
  7. Kisu I., Emoto K., Masugi Y., Yamada Y., Matsubara K., Obara H., Matoba Y., Banno K., Kato Y., Saiki Y., Itagaki I., Kawamoto I., Iwatani C., Murase M., Nakagawa T., Tsuchiya H., Ishigaki H., Urano H., Ema M., Ogasawara K., Aoki D., Nakagawa K., Shiina T. Clinical features of irreversible rejection after allogeneic uterus transplantation in cynomolgus macaques.Sci Rep. 2020;10(1):13910.
  8. Kisu I., Kato Y., Masugi Y., Ishigaki H., Yamada Y., Matsubara K., Obara H., Emoto K., Matoba Y., Adachi M., Banno K., Saiki Y., Sasamura T., Itagaki I., Kawamoto I., Iwatani C., Nakagawa T., Murase M., Tsuchiya H., Urano H., Ema M., Ogasawara K., Aoki D., Nakagawa K., Shiina T. First Successful Delivery after Uterus Transplantation in MHC-Defined Cynomolgus Macaques. J Clin Med. 2020;9(11).
  9. Kubota N., Ojima H., Hatano M., Yamazaki K., Masugi Y., Tsujikawa H., Fujii-Nishimura Y., Ueno A., Kurebayashi Y., Shinoda M., Kitago M., Abe Y., Kitagawa Y., Sakamoto M. Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin. Pathol Int. 2020;70(4):199-209.
  10. Kwa W. T., Effendi K., Yamazaki K., Kubota N., Hatano M., Ueno A., Masugi Y., Sakamoto M. Telomerase reverse transcriptase (TERT) promoter mutation correlated with intratumoral heterogeneity in hepatocellular carcinoma. Pathol Int. 2020;70(9):624-32.
  11. Maehara J., Masugi Y., Abe T., Tsujikawa H., Kurebayashi Y., Ueno A., Ojima H., Okuda S., Jinzaki M., Shinoda M., Kitagawa Y., Oda Y., Honda H., Sakamoto M. Quantification of intratumoral collagen and elastin fibers within hepatocellular carcinoma tissues finds correlations with clinico-patho-radiological features. Hepatol Res. 2020;50(5):607-19.
  12. Minagawa T., Yamazaki K., Masugi Y., Tsujikawa H., Ojima H., Hibi T., Abe Y., Yagi H., Kitago M., Shinoda M., Itano O., Kitagawa Y., Sakamoto M. Activation of extracellular signal-regulated kinase is associated with hepatocellular carcinoma with aggressive phenotypes. Hepatol Res. 2020;50(3):353-64.
  13. Toyama K., Matsusaka Y., Okuda S., Miura E., Kubota N., Masugi Y., Kitago M., Hori S., Yokose T., Shinoda M., Sakamoto M., Jinzaki M. A case of pancreatic hamartoma with characteristic radiological findings: radiological-pathological correlation. Abdom Radiol (NY). 2020;45(7):2244-8.
  14. Udagawa D., Shimazu M., Sakuragawa T., Maruyama S., Uchi Y., Miura E., Masugi Y., Sakamoto M. Surgery for colloid carcinoma of the pancreas with portal vein tumor thrombus: a case report. Surg Case Rep. 2020;6(1):252.
  15. Wagatsuma T., Nagai-Okatani C., Matsuda A., Masugi Y., Imaoka M., Yamazaki K., Sakamoto M., Kuno A. Discovery of Pancreatic Ductal Adenocarcinoma-Related Aberrant Glycosylations: A Multilateral Approach of Lectin Microarray-Based Tissue Glycomic Profiling With Public Transcriptomic Datasets. Front Oncol. 2020;10:338.
  16. Yagi F., Akita H., Ueno A., Takano K., Masugi Y., Sakamoto M., Kitago M., Shinoda M., Kitagawa Y., Toyama K., Matsusaka Y., Yashiro H., Okuda S., Jinzaki M. Incidentally detected microcystic serous cystadenoma of the pancreas with splenic invasion: a case report and literature review. BJR Case Rep. 2020;6(2):20190109.
  17. Yokose T., Kabe Y., Matsuda A., Kitago M., Matsuda S., Hirai M., Nakagawa T., Masugi Y., Hishiki T., Nakamura Y., Shinoda M., Yagi H., Abe Y., Oshima G., Hori S., Nakano Y., Honda K., Kashiro A., Morizane C., Nara S., Kikuchi S., Shibahara T., Itonaga M., Ono M., Minegishi N., Koshiba S., Yamamoto M., Kuno A., Handa H., Sakamoto M., Suematsu M., Kitagawa Y. O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer. Cancers (Basel). 2020;12(9).
  18. Yokose T., Kitago M., Matsuda S., Sasaki Y., Masugi Y., Nakamura Y., Shinoda M., Yagi H., Abe Y., Oshima G., Hori S., Yusuke F., Nakano Y., Endo Y., Abe K., Tokino T., Kitagawa Y. Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer. Cancer Sci. 2020;111(6):2174-82.
  19. Yokose T., Kitago M., Matsusaka Y., Masugi Y., Shinoda M., Yagi H., Abe Y., Oshima G., Hori S., Endo Y., Toyama K., Iwabuchi Y., Takemura R., Ishii R., Nakahara T., Okuda S., Jinzaki M., Kitagawa Y. Usefulness of (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma. Cancer Med. 2020;9(12):4059-68.
  20. Yokose T., Kitago M., Oshima G., Abe K., Masugi Y., Miura E., Shinoda M., Yagi H., Abe Y., Hori S., Matsusaka Y., Endo Y., Toyama K., Okuda S., Kitagawa Y. Urgent distal pancreatectomy for intraperitoneal hemorrhage due to the spontaneous rupture of a pancreatic metastatic tumor from synovial sarcoma: a case report. BMC Surg. 2020;20(1):175.
  21. 谷木 信仁, 中本 伸宏, 吉田 文, ちょ 柏松, 伊倉 顕彦, 山高 果林, 森川 麗, 志波 俊輔, 山口 晃弘, 碓井 真吾, 尾城 啓輔, 海老沼 浩利, 斎藤 英胤, 久保田 直人, 眞杉 洋平, 坂元 亨宇, 金井 隆典. ラジオ波焼灼療法により良好な病勢制御が得られたトロトラスト沈着症による肝内胆管癌の一例. 肝臓. 2020;61(5):262-9.
2019
  1. Masugi Y., Abe T., Ueno A., Fujii-Nishimura Y., Ojima H., Endo Y., Fujita Y., Kitago M., Shinoda M., Kitagawa Y., Sakamoto M. Characterization of spatial distribution of tumor-infiltrating CD8(+) T cells refines their prognostic utility for pancreatic cancer survival. Mod Pathol. 2019;32(10):1495-507.
  2. Hamada T., Nowak J. A., Masugi Y. (co-first author), Drew D. A., Song M., Cao Y., Kosumi K., Mima K., Twombly T. S., Liu L., Shi Y., Da Silva A., Gu M., Li W., Nosho K., Keum N., Giannakis M., Meyerhardt J. A., Wu K., Wang M., Chan A. T., Giovannucci E. L., Fuchs C. S., Nishihara R., Zhang X., Ogino S. Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells. J Natl Cancer Inst. 2019;111(1):42-51.
  3. Endo Y., Kitago M., Aiura K., Shinoda M., Yagi H., Abe Y., Oshima G., Hori S., Nakano Y., Itano O., Fukada J., Masugi Y., Kitagawa Y. Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study. World J Surg Oncol. 2019;17(1):145.
  4. Hatano M., Ojima H., Masugi Y., Tsujikawa H., Hiraoka N., Kanai Y., Shimada K., Shinoda M., Sakamoto M. Steatotic and nonsteatotic scirrhous hepatocellular carcinomas reveal distinct clinicopathological features. Hum Pathol. 2019;86:222-32.
  5. Imaoka M., Tanese K., Masugi Y., Hayashi M., Sakamoto M. Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells. Cancer Sci. 2019;110(7):2273-83.
  6. Kisu I., Ishigaki H., Emoto K., Kato Y., Yamada Y., Matsubara K., Obara H., Masugi Y., Matoba Y., Adachi M., Banno K., Saiki Y., Itagaki I., Kawamoto I., Iwatani C., Nakagawa T., Tsuchiya H., Sasamura T., Urano H., Ema M., Ogasawara K., Aoki D., Nakagawa K., Shiina T. Long-Term Outcome and Rejection After Allogeneic Uterus Transplantation in Cynomolgus Macaques. J Clin Med. 2019;8(10).
  7. Yang W., Liu L., Keum N., Qian Z. R., Nowak J. A., Hamada T., Song M., Cao Y., Nosho K., Smith-Warner S. A., Zhang S., Masugi Y., Ng K., Kosumi K., Ma Y., Garrett W. S., Wang M., Nan H., Giannakis M., Meyerhardt J. A., Chan A. T., Fuchs C. S., Nishihara R., Wu K., Giovannucci E. L., Ogino S., Zhang X. Calcium Intake and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells. Cancer Prev Res (Phila). 2019;12(5):283-94.
  8. Yasui Y., Abe T., Kurosaki M., Matsunaga K., Higuchi M., Tamaki N., Watakabe K., Okada M., Wang W., Shimizu T., Takaura K., Masugi Y., Nakanishi H., Tsuchiya K., Takahashi Y., Itakura J., Sakurai U., Hashiguchi A., Sakamoto M., Izumi N. Non-invasive liver fibrosis assessment correlates with collagen and elastic fiber quantity in patients with hepatitis C virus infection. Hepatol Res. 2019;49(1):33-41.
2018
  1. Masugi Y., Abe T., Tsujikawa H., Effendi K., Hashiguchi A., Abe M., Imai Y., Hino K., Hige S., Kawanaka M., Yamada G., Kage M., Korenaga M., Hiasa Y., Mizokami M., Sakamoto M. Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatol Commun. 2018;2(1):58-68.
  2. Hamada T., Soong T. R., Masugi Y. (co-first author), Kosumi K., Nowak J. A., Da Silva A., Mu X. J., Twombly T. S., Koh H., Yang J., Song M., Liu L., Gu M., Shi Y., Nosho K., Morikawa T., Inamura K., Shukla S. A., Wu C. J., Garraway L. A., Zhang X., Wu K., Meyerhardt J. A., Chan A. T., Glickman J. N., Rodig S. J., Freeman G. J., Fuchs C. S., Nishihara R., Giannakis M., Ogino S. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas. Oncoimmunology. 2018;7(7):e1442999.
  3. Yang W., Liu L., Masugi Y. (co-first author), Qian Z. R., Nishihara R., Keum N., Wu K., Smith-Warner S., Ma Y., Nowak J. A., Momen-Heravi F., Zhang L., Bowden M., Morikawa T., Silva A. D., Wang M., Chan A. T., Fuchs C. S., Meyerhardt J. A., Ng K., Giovannucci E., Ogino S., Zhang X. Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR). Gut. 2018;67(8):1475-83.
  4. Da Silva A, Bowden M, Zhang S, Masugi Y, Thorner AR, Herbert ZT, Zhou CW, Brais L, Chan JA, Hodi FS, Rodig S, Ogino S, Kulke MH. Characterization of the Neuroendocrine Tumor Immune Microenvironment. Pancreas 2018;47(9):1123-9.
  5. Fujii-Nishimura Y., Yamazaki K., Masugi Y., Douguchi J., Kurebayashi Y., Kubota N., Ojima H., Kitago M., Shinoda M., Hashiguchi A., Sakamoto M. Mesenchymal-epithelial transition of pancreatic cancer cells at perineural invasion sites is induced by Schwann cells. Pathol Int. 2018;68(4):214-23.
  6. Fujita Y., Kitago M., Abe T., Itano O., Shinoda M., Abe Y., Yagi H., Hibi T., Ishii M., Nakano Y., Okuma K., Hashimoto M., Takeuchi A., Masugi Y., Jinzaki M., Sakamoto M., Kitagawa Y. Evaluation of Pancreatic Fibrosis With Acoustic Radiation Force Impulse Imaging and Automated Quantification of Pancreatic Tissue Components. Pancreas. 2018;47(10):1277-82.
  7. Hamada T., Liu L., Nowak J. A., Mima K., Cao Y., Ng K., Twombly T. S., Song M., Jung S., Dou R., Masugi Y., Kosumi K., Shi Y., Da Silva A., Gu M., Li W., Keum N., Wu K., Nosho K., Inamura K., Meyerhardt J. A., Nevo D., Wang M., Giannakis M., Chan A. T., Giovannucci E. L., Fuchs C. S., Nishihara R., Zhang X., Ogino S. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour. Eur J Cancer. 2018;103:98-107.
  8. Hamada T., Zhang X., Mima K., Bullman S., Sukawa Y., Nowak J. A., Kosumi K., Masugi Y., Twombly T. S., Cao Y., Song M., Liu L., Da Silva A., Shi Y., Gu M., Li W., Koh H., Nosho K., Inamura K., Keum N., Wu K., Meyerhardt J. A., Kostic A. D., Huttenhower C., Garrett W. S., Meyerson M., Giovannucci E. L., Chan A. T., Fuchs C. S., Nishihara R., Giannakis M., Ogino S. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunol Res. 2018;6(11):1327-36.
  9. Koh H., Hamada T., Song M., Liu L., Cao Y., Nowak J. A., Da Silva A., Twombly T., Morikawa T., Kim S. A., Masugi Y., Kosumi K., Shi Y., Gu M., Li W., Du C., Chen Y., Li W., Liu H., Li C., Wu K., Nosho K., Inamura K., Hanyuda A., Zhang X., Giannakis M., Chan A. T., Fuchs C. S., Nishihara R., Meyerhardt J. A., Ogino S. Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells. JNCI Cancer Spectr. 2018;2(4):pky058.
  10. Kosumi K., Hamada T., Koh H., Borowsky J., Bullman S., Twombly T. S., Nevo D., Masugi Y., Liu L., Da Silva A., Chen Y., Du C., Gu M., Li C., Li W., Liu H., Shi Y., Mima K., Song M., Nosho K., Nowak J. A., Nishihara R., Baba H., Zhang X., Wu K., Wang M., Huttenhower C., Garrett W. S., Meyerson M. L., Lennerz J. K., Giannakis M., Chan A. T., Meyerhardt J. A., Fuchs C. S., Ogino S. The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. Am J Pathol. 2018;188(12):2839-52.
  11. Ma S., Ogino S., Parsana P., Nishihara R., Qian Z., Shen J., Mima K., Masugi Y., Cao Y., Nowak J. A., Shima K., Hoshida Y., Giovannucci E. L., Gala M. K., Chan A. T., Fuchs C. S., Parmigiani G., Huttenhower C., Waldron L. Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. Genome Biol. 2018;19(1):142.
  12. Qian Z. R., Rubinson D. A., Nowak J. A., Morales-Oyarvide V., Dunne R. F., Kozak M. M., Welch M. W., Brais L. K., Da Silva A., Li T., Li W., Masuda A., Yang J., Shi Y., Gu M., Masugi Y., Bui J., Zellers C. L., Yuan C., Babic A., Khalaf N., Aguirre A., Ng K., Miksad R. A., Bullock A. J., Chang D. T., Tseng J. F., Clancy T. E., Linehan D. C., Findeis-Hosey J. J., Doyle L. A., Thorner A. R., Ducar M., Wollison B., Laing A., Hahn W. C., Meyerson M., Fuchs C. S., Ogino S., Hornick J. L., Hezel A. F., Koong A. C., Wolpin B. M. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2018;4(3):e173420.
  13. Ugamura A., Chu P. S., Nakamoto N., Taniki N., Ojiro K., Hibi T., Shinoda M., Obara H., Masugi Y., Yamaguchi A., Shiba S., Morikawa R., Usui S., Ebinuma H., Kitagawa Y., Saito H., Kanai T. Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure. Hepatol Commun. 2018;2(11):1331-43.
  14. 久保田 直人, 下田 将之, 江本 桂, 荒川 和清, 中間 楽平, 横倉 英人, 増田 義洋, 末盛 友浩, 眞杉 洋平. CPC解説　脾破裂をきたした芽球性形質細胞様樹状細胞腫瘍の1剖検例. 病理と臨床. 2018;36(4):385-90.
2017
  1. Masugi Y., Nishihara R., Yang J., Mima K., Da Silva A., Shi Y., Inamura K., Cao Y., Song M., Nowak J. A., Liao X., Nosho K., Chan A. T., Giannakis M., Bass A. J., Hodi F. S., Freeman G. J., Rodig S., Fuchs C. S., Qian Z. R., Ogino S. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Gut. 2017;66(8):1463-73.
  2. Hamada T., Cao Y., Qian Z. R., Masugi Y. (co-first author), Nowak J. A., Yang J., Song M., Mima K., Kosumi K., Liu L., Shi Y., Da Silva A., Gu M., Li W., Keum N., Zhang X., Wu K., Meyerhardt J. A., Giovannucci E. L., Giannakis M., Rodig S. J., Freeman G. J., Nevo D., Wang M., Chan A. T., Fuchs C. S., Nishihara R., Ogino S. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. J Clin Oncol. 2017;35(16):1836-44.
  3. Masugi Y., Nishihara R., Hamada T., Song M., Da Silva A., Kosumi K., Gu M., Shi Y., Li W., Liu L., Nevo D., Inamura K., Cao Y., Liao X., Nosho K., Chan A. T., Giannakis M., Bass A. J., Hodi F. S., Freeman G. J., Rodig S. J., Fuchs C. S., Qian Z. R., Nowak J. A., Ogino S. Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer. Cancer Immunol Res. 2017;5(11):1046-55.
  4. Kosumi K., Masugi Y. (co-first author), Yang J., Qian Z. R., Kim S. A., Li W., Shi Y., Da Silva A., Hamada T., Liu L., Gu M., Twombly T. S., Cao Y., Barbie D. A., Nosho K., Baba H., Garrett W. S., Meyerhardt J. A., Giovannucci E. L., Chan A. T., Fuchs C. S., Ogino S., Nishihara R. Tumor SQSTM1 (p62) expression and T cells in colorectal cancer. Oncoimmunology. 2017;6(3):e1284720.
  5. Momen-Heravi F., Masugi Y. (co-first author), Qian Z. R., Nishihara R., Liu L., Smith-Warner S. A., Keum N., Zhang L., Tchrakian N., Nowak J. A., Yang W., Ma Y., Bowden M., Da Silva A., Wang M., Fuchs C. S., Meyerhardt J. A., Ng K., Wu K., Giovannucci E., Ogino S., Zhang X. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study. Int J Cancer. 2017;141(12):2471-9.
  6. Baba Y, Funakoshi T, Mori M, Emoto K, Masugi Y, Ekmekcioglu S, Amagai M, Tanese K. Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma. J Eur Acad Dermatol Venereol 2017;31(12):2038-45.
  7. Fujii T., Obara H., Matsubara K., Fujimura N., Yagi H., Hibi T., Abe Y., Kitago M., Shinoda M., Itano O., Tanabe M., Masugi Y., Sakamoto M., Kitagawa Y. Oral administration of cilostazol improves survival rate after rat liver ischemia/reperfusion injury. J Surg Res. 2017;213:207-14.
  8. Gu M., Nishihara R., Chen Y., Li W., Shi Y., Masugi Y., Hamada T., Kosumi K., Liu L., Da Silva A., Nowak J. A., Twombly T., Du C., Koh H., Li W., Meyerhardt J. A., Wolpin B. M., Giannakis M., Aguirre A. J., Bass A. J., Drew D. A., Chan A. T., Fuchs C. S., Qian Z. R., Ogino S. Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells. Oncotarget. 2017;8(50):87379-89.
  9. Hanyuda A., Cao Y., Hamada T., Nowak J. A., Qian Z. R., Masugi Y., Da Silva A., Liu L., Kosumi K., Soong T. R., Jhun I., Wu K., Zhang X., Song M., Meyerhardt J. A., Chan A. T., Fuchs C. S., Giovannucci E. L., Ogino S., Nishihara R. Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status. Eur J Epidemiol. 2017;32(5):393-407.
  10. Liu L., Nishihara R., Qian Z. R., Tabung F. K., Nevo D., Zhang X., Song M., Cao Y., Mima K., Masugi Y., Shi Y., Da Silva A., Twombly T., Gu M., Li W., Hamada T., Kosumi K., Inamura K., Nowak J. A., Drew D. A., Lochhead P., Nosho K., Wu K., Wang M., Garrett W. S., Chan A. T., Fuchs C. S., Giovannucci E. L., Ogino S. Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor. Gastroenterology. 2017;153(6):1517-30 e14.
  11. Mehta R. S., Nishihara R., Cao Y., Song M., Mima K., Qian Z. R., Nowak J. A., Kosumi K., Hamada T., Masugi Y., Bullman S., Drew D. A., Kostic A. D., Fung T. T., Garrett W. S., Huttenhower C., Wu K., Meyerhardt J. A., Zhang X., Willett W. C., Giovannucci E. L., Fuchs C. S., Chan A. T., Ogino S. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue. JAMA Oncol. 2017;3(7):921-7.
  12. Mehta R. S., Song M., Nishihara R., Drew D. A., Wu K., Qian Z. R., Fung T. T., Hamada T., Masugi Y., Da Silva A., Shi Y., Li W., Gu M., Willett W. C., Fuchs C. S., Giovannucci E. L., Ogino S., Chan A. T. Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes. Gastroenterology. 2017;152(8):1944-53 e1.
  13. Shi Y., Qian Z. R., Zhang S., Li W., Masugi Y., Li T., Chan J. A., Yang J., Da Silva A., Gu M., Liu L., Hamada T., Kosumi K., Dutton T., Brais L. K., Nishihara R., Fuchs C. S., Ogino S., Kulke M. H. Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index. Pancreas. 2017;46(10):1347-53.
  14. Yamada M., Shibata H., Masugi Y., Ishi T., Kameyama K., Ebinuma H., Hasegawa T. Histological Changes in Autoimmune Hepatitis with Graves' Disease: A Child Case Report. Intern Med. 2017;56(16):2139-43.
  15. 益田 悠貴, 板野 理, 尾島 英知, 篠田 昌宏, 北郷 実, 八木 洋, 阿部 雄太, 日比 泰造, 川井田 みほ, 真杉 洋平, 坂元 亨宇, 北川 雄光. 胆管内に限局する再発形式を示した肝細胞癌の1切除例. Liver Cancer. 2017;23:59-63.
2016
  1. Dou R, Nishihara R, Cao Y, Hamada T, Mima K, Masuda A, Masugi Y, Shi Y, Gu M, Li W, Da Silva A, Nosho K, Zhang X, Meyerhardt JA, Giovannucci EL, Chan AT, Fuchs CS, Qian ZR, Ogino S. MicroRNA let-7, T cells, and patient survival in colorectal cancer. Cancer Immunol Res 2016;4(11):927-35.
  2. Kishida N., Matsuda S., Itano O., Shinoda M., Kitago M., Yagi H., Abe Y., Hibi T., Masugi Y., Aiura K., Sakamoto M., Kitagawa Y. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. BMC Gastroenterol. 2016;16(1):61.
  3. Hanyuda A., Ogino S., Qian Z. R., Nishihara R., Song M., Mima K., Inamura K., Masugi Y., Wu K., Meyerhardt J. A., Chan A. T., Fuchs C. S., Giovannucci E. L., Cao Y. Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate.Int J Cancer. 2016;139(4):854-68.
  4. Mima K., Cao Y., Chan A. T., Qian Z. R., Nowak J. A., Masugi Y., Shi Y., Song M., Da Silva A., Gu M., Li W., Hamada T., Kosumi K., Hanyuda A., Liu L., Kostic A. D., Giannakis M., Bullman S., Brennan C. A., Milner D. A., Baba H., Garraway L. A., Meyerhardt J. A., Garrett W. S., Huttenhower C., Meyerson M., Giovannucci E. L., Fuchs C. S., Nishihara R., Ogino S. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol. 2016;7(11):e200.
  5. Mima K., Nishihara R., Qian Z. R., Cao Y., Sukawa Y., Nowak J. A., Yang J., Dou R., Masugi Y., Song M., Kostic A. D., Giannakis M., Bullman S., Milner D. A., Baba H., Giovannucci E. L., Garraway L. A., Freeman G. J., Dranoff G., Garrett W. S., Huttenhower C., Meyerson M., Meyerhardt J. A., Chan A. T., Fuchs C. S., Ogino S. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016;65(12):1973-80.
  6. Mima K., Nishihara R., Yang J., Dou R., Masugi Y., Shi Y., Da Silva A., Cao Y., Song M., Nowak J., Gu M., Li W., Morikawa T., Zhang X., Wu K., Baba H., Giovannucci E. L., Meyerhardt J. A., Chan A. T., Fuchs C. S., Qian Z. R., Ogino S. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.Clin Cancer Res. 2016;22(15):3841-8.
  7. Mima K., Nowak J. A., Qian Z. R., Cao Y., Song M., Masugi Y., Shi Y., Da Silva A., Gu M., Li W., Hamada T., Zhang X., Wu K., Meyerhardt J. A., Baba H., Giovannucci E. L., Chan A. T., Fuchs C. S., Ogino S., Nishihara R. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.Oncotarget. 2016;7(34):55098-109.
  8. Ojima H., Masugi Y., Tsujikawa H., Emoto K., Fujii-Nishimura Y., Hatano M., Kawaida M., Itano O., Kitagawa Y., Sakamoto M. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions. Cancer Sci. 2016;107(4):543-50.
  9. Qian Z. R., Li T., Ter-Minassian M., Yang J., Chan J. A., Brais L. K., Masugi Y., Thiaglingam A., Brooks N., Nishihara R., Bonnemarie M., Masuda A., Inamura K., Kim S. A., Mima K., Sukawa Y., Dou R., Lin X., Christiani D. C., Schmidlin F., Fuchs C. S., Mahmood U., Ogino S., Kulke M. H. Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors. Pancreas. 2016;45(10):1386-93.
  10. Song M., Nishihara R., Cao Y., Chun E., Qian Z. R., Mima K., Inamura K., Masugi Y., Nowak J. A., Nosho K., Wu K., Wang M., Giovannucci E., Garrett W. S., Fuchs C. S., Ogino S., Chan A. T. Marine omega-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells. JAMA Oncol. 2016;2(9):1197-206.
  11. Tomita H., Ohkuma K., Masugi Y., Hosoe N., Hoshino K., Fuchimoto Y., Fujino A., Shimizu T., Kato M., Fujimura T., Ishihama H., Takahashi N., Tanami Y., Ebinuma H., Saito H., Sakamoto M., Nakano M., Kuroda T. Diagnosing native liver fibrosis and esophageal varices using liver and spleen stiffness measurements in biliary atresia: a pilot study. Pediatr Radiol. 2016;46(10):1409-17.
  12. Tsujikawa H., Masugi Y., Yamazaki K., Itano O., Kitagawa Y., Sakamoto M. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness. Hum Pathol. 2016;50:24-33.
  13. 熊谷 宜子, 舩越 建, 新川 宏樹, 種瀬 啓士, 川崎 洋, 眞杉 洋平, 亀山 香織. 前腕皮下に生じたEpithelioid Hemangioendotheliomaの1例. 皮膚科の臨床. 2016;58(7):1175-9.
2015以前
  1. Masugi Y., Yamazaki K., Emoto K., Effendi K., Tsujikawa H., Kitago M., Itano O., Kitagawa Y., Sakamoto M. Upregulation of integrin beta4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma. Lab Invest. 2015;95(3):308-19.
  2. Masugi Y., Tanese K., Emoto K., Yamazaki K., Effendi K., Funakoshi T., Mori M., Sakamoto M. Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma. Pathol Int. 2015;65(12):627-34.
  3. Fujii-Nishimura Y., Nishiyama R., Kitago M., Masugi Y., Ueno A., Aiura K., Kawachi S., Kawaida M., Abe Y., Shinoda M., Itano O., Tanimoto A., Sakamoto M., Kitagawa Y. Two Cases of Pathological Complete Response to Neoadjuvant Chemoradiation Therapy in Pancreatic Cancer. Keio J Med. 2015;64(2):26-31.
  4. Fukuda K., Funakoshi T., Fukuyama M., Kakuta R., Sato M., Nakamura Y., Tanese K., Masugi Y., Amagai M. Metastatic eccrine porocarcinoma successfully treated with carboplatin and epirubicin chemotherapy. J Dermatol. 2015;42(9):928-30.
  5. Itano O., Oshima G., Minagawa T., Shinoda M., Kitago M., Abe Y., Hibi T., Yagi H., Ikoma N., Aiko S., Kawaida M., Masugi Y., Kameyama K., Sakamoto M., Kitagawa Y. Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma. Surg Endosc. 2015;29(12):3600-7.
  6. Nogami Y., Banno K., Irie H., Iida M., Kisu I., Masugi Y., Tanaka K., Tominaga E., Okuda S., Murakami K., Aoki D. The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it. Jpn J Clin Oncol. 2015;45(1):26-34.
  7. Nogami Y., Banno K., Irie H., Iida M., Masugi Y., Murakami K., Aoki D. Efficacy of 18-FDG PET-CT dual-phase scanning for detection of lymph node metastasis in gynecological cancer. Anticancer Res. 2015;35(4):2247-53.
  8. Shinoda M., Kishida N., Itano O., Ei S., Ueno A., Kitago M., Abe Y., Hibi T., Yagi H., Masugi Y., Tanabe M., Aiura K., Sakamaoto M., Tanimoto A., Kitagawa Y. Long-term complete response of advanced hepatocellular carcinoma treated with multidisciplinary therapy including reduced dose of sorafenib: case report and review of the literature. World J Surg Oncol. 2015;13:144.
  9. Soma H., Miyata N., Hozawa S., Higuchi H., Yamagishi Y., Nakamura Y., Saeki K., Kameyama K., Masugi Y., Yahagi N., Kanai T. Ampullary Adenoma Treated by Endoscopic Double-Snare Retracting Papillectomy. Gut Liver. 2015;9(5):689-92.
  10. Takada S., Hoshino Y., Ito H., Masugi Y., Terauchi T., Endo K., Kimata M., Furukawa J., Shinozaki H., Kobayashi K., Ogata Y. Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature. Jpn J Clin Oncol. 2015;45(3):286-90.
  11. Tanaka M., Shinoda M., Takayanagi A., Oshima G., Nishiyama R., Fukuda K., Yagi H., Hayashida T., Masugi Y., Suda K., Yamada S., Miyasho T., Hibi T., Abe Y., Kitago M., Obara H., Itano O., Takeuchi H., Sakamoto M., Tanabe M., Maruyama I., Kitagawa Y. Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure model. J Surg Res. 2015;194(2):571-80.
  12. Tomita H., Fuchimoto Y., Fujino A., Hoshino K., Yamada Y., Masugi Y., Sakamoto M., Kasahara M., Kanamori Y., Nakazawa A., Yoshida F., Akatsuka S., Nakano M., Kuroda T. Development and Validation of a Novel Fibrosis Marker in Biliary Atresia during Infancy. Clin Transl Gastroenterol. 2015;6(11):e127.
  13. Ueno A., Masugi Y., Yamazaki K., Komuta M., Effendi K., Tanami Y., Tsujikawa H., Tanimoto A., Okuda S., Itano O., Kitagawa Y., Kuribayashi S., Sakamoto M. OATP1B3 expression is strongly associated with Wnt/beta-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. J Hepatol. 2014;61(5):1080-7.
  14. Masugi Y., Effendi K., Tsujikawa H., Hiraoka N., Kitago M., Shinoda M., Itano O., Tanabe M., Kitagawa Y., Sakamoto M. Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma. Lab Invest. 2014;94(6):683-91.
  15. Masugi Y., Yamazaki K., Effendi K., Tsujikawa H., Tanabe M., Kitagawa Y., Sakamoto M. Presence of primary cilia in cancer cells correlates with prognosis of pancreatic ductal adenocarcinoma. Hum Pathol. 2014;45(4):817-25.
  16. Kishida N., Shinoda M., Masugi Y., Itano O., Fujii-Nishimura Y., Ueno A., Kitago M., Hibi T., Abe Y., Yagi H., Tanimoto A., Tanabe M., Sakamaoto M., Kitagawa Y. Cystic tumor of the liver without ovarian-like stroma or bile duct communication: two case reports and a review of the literature. World J Surg Oncol. 2014;12:229.
  17. Kisu I., Mihara M., Banno K., Hara H., Masugi Y., Araki J., Iida T., Yamada Y., Kato Y., Shiina T., Suganuma N., Aoki D. Uterus allotransplantation in cynomolgus macaque: a preliminary experience with non-human primate models. J Obstet Gynaecol Res. 2014;40(4):907-18.
  18. Tomita H., Masugi Y., Hoshino K., Fuchimoto Y., Fujino A., Shimojima N., Ebinuma H., Saito H., Sakamoto M., Kuroda T. Long-term native liver fibrosis in biliary atresia: development of a novel scoring system using histology and standard liver tests. J Hepatol. 2014;60(6):1242-8.
  19. Effendi K., Yamazaki K., Mori T., Masugi Y., Makino S., Sakamoto M. Involvement of hepatocellular carcinoma biomarker, cyclase-associated protein 2 in zebrafish body development and cancer progression. Exp Cell Res. 2013;319(1):35-44.
  20. Fukuma M., Tanese K., Effendi K., Yamazaki K., Masugi Y., Suda M., Sakamoto M. Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells. Exp Cell Res. 2013;319(3):113-21.
  21. Hoshino Y., Shinozaki H., Kimura Y., Masugi Y., Ito H., Terauchi T., Kimata M., Furukawa J., Kobayashi K., Ogata Y. Pancreatic metastases from renal cell carcinoma: a case report and literature review of the clinical and radiological characteristics. World J Surg Oncol. 2013;11:289.
  22. Joishi D., Ueno A., Tanimoto A., Okuda S., Masugi Y., Emoto K., Okuma K., Sakamoto M., Imai Y., Kuribayashi S. Natural course of hypovascular nodules detected on gadoxetic acid-enhanced MR imaging: presence of fat is a risk factor for hypervascularization. Magn Reson Med Sci. 2013;12(4):281-7.
  23. Kabashima-Niibe A., Higuchi H., Takaishi H., Masugi Y., Matsuzaki Y., Mabuchi Y., Funakoshi S., Adachi M., Hamamoto Y., Kawachi S., Aiura K., Kitagawa Y., Sakamoto M., Hibi T. Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells. Cancer Sci. 2013;104(2):157-64.
  24. Kadota Y., Shinoda M., Tanabe M., Tsujikawa H., Ueno A., Masugi Y., Oshima G., Nishiyama R., Tanaka M., Mihara K., Abe Y., Yagi H., Kitago M., Itano O., Kawachi S., Aiura K., Tanimoto A., Sakamaoto M., Kitagawa Y. Concomitant pancreatic endocrine neoplasm and intraductal papillary mucinous neoplasm: a case report and literature review. World J Surg Oncol. 2013;11:75.
  25. Kisu I., Banno K., Lin L. Y., Ueno A., Abe T., Kouyama K., Okuda S., Masugi Y., Umene K., Nogami Y., Tsuji K., Masuda K., Ueki A., Kobayashi Y., Yamagami W., Susumu N., Aoki D. Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer: comparison of magnetic resonance imaging and frozen sections. Acta Obstet Gynecol Scand. 2013;92(5):525-35.
  26. Shinoda M., Kadota Y., Tsujikawa H., Masugi Y., Itano O., Ueno A., Mihara K., Hibi T., Abe Y., Yagi H., Kitago M., Kawachi S., Tanimoto A., Sakamoto M., Tanabe M., Kitagawa Y. Lymphoepithelioma-like hepatocellular carcinoma: a case report and a review of the literature. World J Surg Oncol. 2013;11:97.
  27. Tomita H., Hoshino K., Fuchimoto Y., Ebinuma H., Ohkuma K., Tanami Y., Du W., Masugi Y., Shimojima N., Fujino A., Kano M., Fujimura T., Ishihama H., Shimizu T., Tanabe M., Saito H., Sakamoto M., Hibi T., Kitagawa Y., Kuroda T. Acoustic radiation force impulse imaging for assessing graft fibrosis after pediatric living donor liver transplantation: a pilot study. Liver Transpl. 2013;19(11):1202-13.
  28. Aiura K, Hibi T, Fujisaki H, Kitago M, Tanabe M, Kawachi S, Itano O, Shinoda M, Yagi H, Masugi Y, Sakamoto M, Kitagawa Y. Proposed indications for limited resection of early ampulla of Vater carcinoma: Clinico-histopathological criteria to confirm cure. J Hepatobiliary Pancreat Sci 2012;19(6):707-16.
  29. Oshima G., Shinoda M., Tanabe M., Ebinuma H., Nishiyama R., Takano K., Yamada S., Miyasho T., Masugi Y., Matsuda S., Suda K., Fukunaga K., Matsubara K., Hibi T., Yagi H., Hayashida T., Yamagishi Y., Obara H., Itano O., Takeuchi H., Kawachi S., Saito H., Hibi T., Maruyama I., Kitagawa Y. Increased plasma levels of high mobility group box 1 in patients with acute liver failure. Eur Surg Res. 2012;48(3):154-62.
  30. Oshima G., Shinoda M., Tanabe M., Masugi Y., Ueno A., Takano K., Kitago M., Itano O., Kawachi S., Ohara K., Oda M., Tanimoto A., Sakamaoto M., Kitagawa Y. Primary hepatic cancers with multiple pathologic features in a patient with hepatitis C: report of a case. Int Surg. 2012;97(1):17-22.
  31. Umeda R., Nakamura Y., Masugi Y., Shinoda M., Hosoe N., Ono Y., Fujimura T., Yamagishi Y., Higuchi H., Ebinuma H., Hozawa S., Tanabe M., Hashimoto S., Sakamoto M., Kitagawa Y., Hibi T. Hemobilia due to biliary intraepithelial neoplasia associated with Zollinger-Ellison syndrome. Clin J Gastroenterol. 2012;5(3):189-94.
  32. Yoshida G. J., Fuchimoto Y., Osumi T., Shimada H., Hosaka S., Morioka H., Mukai M., Masugi Y., Sakamoto M., Kuroda T. Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapy. BMC Cancer. 2012;12:444.
  33. Kanamori H., Kawakami T., Effendi K., Yamazaki K., Mori T., Ebinuma H., Masugi Y., Du W., Nagasaka K., Ogiwara A., Kyono Y., Tanabe M., Saito H., Hibi T., Sakamoto M. Identification by differential tissue proteome analysis of talin-1 as a novel molecular marker of progression of hepatocellular carcinoma. Oncology. 2011;80(5-6):406-15.
  34. Nishiyama R., Shinoda M., Tanabe M., Masugi Y., Ueno A., Hibi T., Takano K., Fujisaki H., Kitago M., Itano O., Kawachi S., Aiura K., Tanimoto A., Sakamaoto M., Kitagawa Y. Intrahepatic cholangiocarcinoma arising 33 years after excision of a choledochal cyst: report of a case. Int Surg. 2011;96(4):320-5.
  35. Effendi K., Mori T., Komuta M., Masugi Y., Du W., Sakamoto M. Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression. Cancer Sci. 2010;101(3):666-72.
  36. Mamiya T., Yamazaki K., Masugi Y., Mori T., Effendi K., Du W., Hibi T., Tanabe M., Ueda M., Takayama T., Sakamoto M. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest. 2010;90(9):1339-45.
  37. Masugi Y., Yamazaki K., Hibi T., Aiura K., Kitagawa Y., Sakamoto M. Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer. Hum Pathol. 2010;41(8):1061-8.
  38. Uchida R., Masugi Y., Nishizawa T., Kimura T., Yamada T. Extensive endobronchial growth of metastatic hepatocellular carcinoma resulting in respiratory failure: a case report. Pathol Res Pract. 2010;206(2):116-20.
  39. Shinoda M., Aiura K., Yamagishi Y., Masugi Y., Takano K., Maruyama S., Irino T., Takabayashi K., Hoshino Y., Nishiya S., Hibi T., Kawachi S., Tanabe M., Ueda M., Sakamoto M., Hibi T., Kitagawa Y. Bouveret's syndrome with a concomitant incidental T1 gallbladder cancer. Clin J Gastroenterol. 2010;3(5):248-53.
  40. Takano K., Shinoda M., Tanabe M., Miyasho T., Yamada S., Ono S., Masugi Y., Suda K., Fukunaga K., Hayashida T., Hibi T., Obara H., Takeuchi H., Kawachi S., Kawasako K., Okamoto M., Yokota H., Maruyama I., Kitagawa Y. Protective effect of high-mobility group box 1 blockade on acute liver failure in rats. Shock. 2010;34(6):573-9.
  41. Yamazaki K., Takamura M., Masugi Y., Mori T., Du W., Hibi T., Hiraoka N., Ohta T., Ohki M., Hirohashi S., Sakamoto M. Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Lab Invest. 2009;89(4):425-32.
  42. Masugi Y., Kameyama K., Aiba M., Mukai M., Hara S., Ohigashi T., Murai M. Non-functional adrenocortical adenoma with extensive degeneration. Pathol Int. 2003;53(4):241-5.
  43. 森本 亜里, 舩越 建, 福島 彩乃, 久保 亮治, 海老原 全, 林田 哲, 真杉 洋平, 亀山 香織, 永尾 圭介. 単純ヘルペスウイルスの再活性化による口腔内・食道潰瘍を呈した薬剤性過敏症症候群の1例. 臨床皮膚科. 2014;68(11):873-8.
  44. 猪股 研太, 板野 理, 眞杉 洋平, 阿部 雄太, 篠田 昌宏, 北郷 実, 八木 洋, 日比 泰造, 石井 政嗣, 坂元 亨宇, 北川 雄光. 生体部分肝移植7年後に発生した多血性肝腫瘤の1症例. Liver Cancer. 2014;20:19-24.
  45. 波多野 まみ, 尾島 英知, 真杉 洋平, 上野 彰久, 阿部 雄太, 日比 泰造, 八木 洋, 北郷 実, 篠田 昌宏, 板野 理, 北川 雄光, 坂元 亨宇. 術前診断が困難で病理学的にも問題となった肝過誤腫様病変の1例. Liver Cancer. 2014;20:53-7.
  46. 小倉 崇以, 高橋 秀徳, 大久保 光修, 須藤 晃彦, 千代谷 厚, 仲地 一郎, 木村 吉成, 田島 敦志, 黄 英文, 真杉 洋平. 肺炎の治療経過中に真菌性心筋膿瘍を呈した1剖検例. 日本胸部臨床. 2013;72(6):670-7.
  47. 西山 亮, 相浦 浩一, 北郷 実, 篠田 昌宏, 板野 理, 河地 茂行, 田辺 稔, 上田 政和, 真杉 洋平, 坂元 亨宇, 北川 雄光. 術前化学放射線療法後膵頭十二指腸切除術を施行し、長期生存を認めた腹膜播種によるStage IVb膵頭部癌の1例. 膵臓. 2012;27(1):62-8.
  48. 武田 彩乃, 真杉 洋平, 門川 俊明, 石黒 喜美子, 武光 智子, 原 義和, 伊東 大介, 橋口 明典, 小西 孝之助, 林 松彦, 伊藤 裕. 血液透析患者に発症した小脳・脳幹型進行性多巣性白質脳症の1例. 日本透析医学会雑誌. 2010;43(9):807-13. 平野 佑樹, 篠田 昌宏, 田辺 稔, 真杉 洋平, 坂元 亨宇, 北川 雄光. 閉塞性黄疸を呈した肝内胆管嚢胞腺腫の1切除例. 手術. 2010;64(2):259-64.
  49. 鹿股 宏之, 小林 健二, 加瀬 建一, 篠崎 浩治, 河野 勲, 真杉 洋平. 原発性胆嚢管癌の1例. 臨床外科. 2009;64(10):1435-9.
  50. 谷 紀幸, 相浦 浩一, 河地 茂行, 小野 嘉大, 大島 剛, 山岸 由幸, 朴沢 重成, 真杉 洋平, 亀山 香織, 向井 萬起男, 北川 雄光. EPST後に肉眼形態が変化し診断に苦慮した非露出腫瘤型乳頭部癌の1例. Progress of Digestive Endoscopy. 2009;75(2):120-1,9.
  51. 白畑 亨, 加行 淳子, 田坂 定智, 副島 研造, 長谷川 直樹, 石坂 彰敏, 下田 将之, 真杉 洋平. 左胸水ドレナージ後に再膨張性肺水腫による急性呼吸不全を来した1例. 呼吸. 2008;27(8):832-6.

総説・解説

  • Masugi Y. The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities. Cancers (Basel). 2022;14(13).
  • Kisu I., Banno K., Matoba Y., Yamada Y., Emoto K., Masugi Y., Matsubara K., Obara H., Aoki D. Keio Uterus Transplantation Research: From Basic Research toward Future Clinical Application. Keio J Med. 2022;71(2):33-43.
  • Ueno A., Masugi Y., Yamazaki K., Kurebayashi Y., Tsujikawa H., Effendi K., Ojima H., Sakamoto M. Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinoma. Pathol Int. 2020;70(3):140-54.
  • Sakamoto M., Effendi K., Masugi Y. Molecular diagnosis of multistage hepatocarcinogenesis. Jpn J Clin Oncol. 2010;40(9):891-6.
  • Sakamoto M., Mori T., Masugi Y., Effendi K., Rie I., Du W. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma. Intervirology. 2008;51 Suppl 1:42-5.
  • Yamazaki K., Masugi Y., Sakamoto M. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-beta signaling in hepatocarcinogenesis. Dig Dis. 2011;29(3):284-8.
  • 末松 誠, 眞杉 洋平, 久保 亜紀子, 山本 雄広, 早川 典代, 菱木 貴子, 林田 哲. 【オルガノイドがもたらすライフサイエンス革命　あなたの研究に、どう使う?進化と深化を生む未来型研究30選】(第2章)オルガノイド生命医科学研究を飛躍させるテクノロジー　イメージングメタボロミクスを用いたがんの代謝システム制御機構の解明. 実験医学. 2024;42(5):783-7.
  • 眞杉 洋平. 【病理形態学キーワード2024】(第9章)胆・膵　腺房導管化生. 病理と臨床. 2024;42(臨増):194-5.
  • 眞杉 洋平. 【微小環境から読み解く胆膵癌】膵癌　膵癌における癌関連線維芽細胞の多様性. 肝胆膵. 2024;88(5):539-44.
  • 眞杉 洋平. 【病理形態学キーワード2024】(第9章)胆・膵　偽乳頭状構築. 病理と臨床. 2024;42(臨増):210-1.
  • 眞杉 洋平. 【病理形態学キーワード2024】(第9章)胆・膵　brush border-like zone. 病理と臨床. 2024;42(臨増):206-7.
  • 眞杉 洋平. 【病理形態学キーワード2024】(第9章)胆・膵　花筵状線維化. 病理と臨床. 2024;42(臨増):198-9.
  • 眞杉 洋平. 【病理形態学キーワード2024】(第9章)胆・膵　膵脂肪置換/膵脂肪腫症. 病理と臨床. 2024;42(臨増):196-7.
  • 阿部 時也, 眞杉 洋平, 坂元 亨宇. 【肝胆膵診療のDX(デジタルトランスフォーメーション)新時代】肝胆膵診療のデジタル化の現状　病理診断のDX化の現状と課題. 肝胆膵. 2023;86(2):229-37.
  • 里井 壯平, 橋本 大輔, 大池 信之, 谷 眞至, 平林 健一, 藤井 努, 眞杉 洋平, 上野 誠, 中井 陽介, 石田 晶玄, 海野 倫明. 【膵癌取扱い規約第8版?変更の要点?】CYに関する変更点. 胆と膵. 2023;44(10):947-50.
  • 眞杉 洋平. 【膵癌取扱い規約第8版?変更の要点?】切除標本の取り扱い　ゲノム診断を含めて. 胆と膵. 2023;44(10):981-6.
  • 眞杉 洋平. 【新しい技術で解明されてきた膵臓の病態】膵癌組織イメージングによる線維芽細胞サブタイプの同定,膵癌間質多様性の特徴化. 膵臓. 2023;38(1):28-36.
  • 坂元 亨宇, 眞杉 洋平, 波多野 悦朗, 正宗 淳. 【膵癌診療のパラダイムシフト】膵癌の診断・治療の近未来. 肝胆膵. 2022;84(2):245-55.
  • 眞杉 洋平. 【膵癌診療のパラダイムシフト】膵癌研究における最近の知見　膵癌における線維性間質、線維芽細胞サブタイプの意義. 肝胆膵. 2022;84(2):239-44.
  • 眞杉 洋平. 【膵臓の発生・生理・解剖から膵炎・膵癌の病態解明に至る最新の知見】膵癌組織イメージングにより見出された3種類の膵癌間質タイプ. 胆と膵. 2022;43(8):801-7.
  • 上野 彰久, 眞杉 洋平, 坂元 亨宇. 【肝細胞性腫瘍の分類・亜分類の最前線】肝細胞癌　病理組織亜型(WHO分類第5版2019). 肝胆膵. 2020;80(4):581-8.
  • 上野 彰久, 眞杉 洋平, 阿部 時也, 坂元 亨宇. 【診断と治療のABC[142]ウイルス性肝炎】(第2章)病理・病態生理　ウイルス性肝炎の病理像と組織分類. 最新医学. 2019;別冊(ウイルス性肝炎):47-56.
  • 眞杉 洋平, 坂元 亨宇. 【Post SVR時代のC型肝炎診療】Post SVRの諸問題　C型肝炎からの発癌の特徴とC型肝炎治療による肝組織病態の変化. 肝・胆・膵. 2019;78(4):593-8.
  • 内田 克典, 眞杉 洋平. 【膵癌取扱い規約第7版の解説と主な変更点】組織学的治療効果判定について. 膵臓. 2016;31(6):812-7.
  • 眞杉 洋平, 内田 克典. 【膵癌取扱いに関する新たな知見と基準】膵癌治療効果に関する病理組織学的判定基準. 病理と臨床. 2016;34(8):832-7.
  • 坂元 亨宇, 相島 慎一, 中島 収, 眞杉 洋平. 肝細胞癌の病理学的多様性. The Liver Cancer Journal. 2015;7(2):89-98.
  • 岩渕 雄, 中原 理紀, 眞杉 洋平, 片桐 真理, 松坂 陽至, 緒方 雄史, 古賀 清子, 村上 康二, 陣崎 雅弘. ちょっと気になる胆・膵画像　ティーチングファイルから(第24回)　FDG集積が病理組織学的悪性度を反映したPNETの1例. 胆と膵. 2014;35(11):1241-4.
  • 真杉 洋平, 坂元 亨宇. 【肝癌のトピックス】早期肝癌診断と肝癌バイオマーカー. 病理と臨床. 2014;32(12):1331-7.
  • 真杉 洋平, 坂元 亨宇. 【免疫組織化学　診断と治療選択の指針】(第2部)腫瘍の鑑別に用いられる抗体(各臓器別)　 肝. 病理と臨床. 2014;32(臨増):125-31.
  • 山崎 剣, 真杉 洋平, 坂元 亨宇. 【早期肝細胞癌の画像診断update】早期肝細胞癌の分子病理. 肝胆膵画像. 2012;14(4):297-302.
  • 目で見る肝癌　肝細胞腺腫と限局性結節性過形成. The Liver Cancer Journal. 2012;4(4):239-44.
  • 上野 彰久, 真杉 洋平, 谷本 伸弘, 坂元 亨宇. 目で見る肝癌　Gd-EOB-DTPA造影MRIにおける乏血性の偽病変. The Liver Cancer Journal. 2012;4(1):5-13.
  • 上野 彰久, 真杉 洋平, 谷本 伸弘, 坂元 亨宇. 目で見る肝癌　硬化型肝細胞癌と混合型肝癌、早期肝細胞癌の多発症例. The Liver Cancer Journal. 2012;4(2):79-87.
  • 上野 彰久, 真杉 洋平, 辻川 華子, 谷本 伸弘, 坂元 亨宇. 目で見る肝癌　典型的細胆管細胞癌の1例. The Liver Cancer Journal. 2012;4(3):166-70.
  • 真杉 洋平, 坂元 亨宇. 【肝癌診療の最前線-知っておきたい診断・治療の新情報】肝癌の発生・進展の分子病態. 内科. 2012;109(3):455-8.
  • 真杉 洋平, 坂元 亨宇. 【肝細胞癌update 2012】肝細胞癌病理診断の最近の話題. 外科. 2012;74(2):126-30.
  • 上野 彰久, 奥田 茂男, 谷本 伸弘, 村上 康二, 大島 剛, 相浦 浩一, 田邊 稔, 真杉 洋平, 木村 徳宏. ちょっと気になる胆・膵画像　ティーチングファイルから(第10回)　膵内副脾に発生したEpidermoidの1例. 胆と膵. 2011;32(7):566-9.
  • 上野 彰久, 真杉 洋平, 坂元 亨宇. 【All About Gd-EOB-DTPA MRI】肝細胞癌の病理診断　多段階発癌の初期像を中心に. 臨床画像. 2011;27(3):274-81.
  • 真杉 洋平, 坂元 亨宇. 【肝細胞がん診療の進歩:Up-To-Date】基礎　肝細胞がんの分子病理. 最新医学. 2011;66(8):1746-52.
  • 上野 彰久, 真杉 洋平, 坂元 亨宇. Clinical Challenge　この画像から何が読めるか?　肝腫瘤. 肝胆膵画像. 2010;12(6):794-8.
  • 真杉 洋平, 坂元 亨宇. 【肝がんの治療戦略　最近の動向】肝細胞がんの病理診断のupdate. 腫瘍内科. 2010;6(5):425-30.
  • 入江 理恵, 真杉 洋平, 坂元 亨宇. 臨床医に役立つ実践病理診断　病理医から臨床医へのメッセージ　肝細胞癌. 肝胆膵画像. 2010;12(5):636-40.
  • 山崎 剣, 真杉 洋平, 坂元 亨宇. 【病態の理解と治療をめざす　癌と微小環境　癌幹細胞、浸潤・転移、血管新生のメカニズムと環境応答を標的とした治療・創薬の新展開】癌と間質の相互作用　膵癌の浸潤・転移におけるEMTの役割. 実験医学. 2009;27(2):230-4.
  • 相浦 浩一, 真杉 洋平, 緒方 晴彦. 【十二指腸隆起性病変をみたら】十二指腸隆起性病変アトラス　十二指腸乳頭部腺腫. 消化器内視鏡. 2009;21(10):1588-9.
  • 杜 ぶん林, 森 泰昌, 真杉 洋平, 坂元 亨宇. 【肝癌　基礎・臨床研究のアップデート】原発性肝癌の分類と病理学的特徴　混合型肝癌(肝細胞癌と肝内胆管癌の混合型). 日本臨床. 2009;67(増刊3 肝癌):71-4.
  • 杜 ぶん林, 真杉 洋平, 森 泰昌, 坂元 亨宇. 【ウイルス性肝炎のプライマリケア】慢性ウイルス性肝炎の診断と経過観察　ウイルス性肝炎の肝組織像. 診断と治療. 2008;96(3):443-8.

著書

  • Japan Pancreas Society. Classification of pancreatic carcinoma, Fourth English Edition. 4th English ed. Tokyo: Kanehara; 2017.　分担執筆
  • 日本膵臓学会編. 膵癌取扱い規約（第8版）金原出版2023.　分担執筆
  • 眞杉 洋平, 坂元 亨宇. 多発肝細胞癌における多中心性発生と肝内転移. 坂元　亨宇, 原田 憲一編. 腫瘍鑑別アトラス肝癌（第2版）． 文光堂2020. p. 225-229.
  • 日本膵臓学会編. 膵癌取扱い規約（第7版増補版）金原出版2020.　分担執筆
  • 日本膵臓学会編. 膵癌取扱い規約（第7版）金原出版2015.　分担執筆
  • 眞杉 洋平, 坂元 亨宇. 肝細胞癌の多中心性発生と肝内転移. 中沼 安二, 坂元　亨宇編. 腫瘍鑑別アトラス肝癌. 文光堂2010. p. 185-189.
  • 眞杉 洋平, 向井 万起男. 病理報告書に必要な記載. 八尾 隆史編. 腫瘍鑑別アトラス大腸癌. 文光堂2011. p. 283-290.